Oceanía · Actualidad general · The Sydney Morning Herald

Amplia uncovers new clue in pancreatic cancer drug trial

Publicado por The Sydney Morning Herald · Australia hace 9 h

Amplia Therapeutics has advanced its cancer drug narmafotinib across four trials, with data suggesting it may work independently of common tumour-causing KRAS gene mutations.

Leer el artículo completo en The Sydney Morning Herald Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.smh.com.au)

Amplia uncovers new clue in pancreatic cancer drug trial

También te puede interesar

Player ratings: From the determined and a hundred to a captain’s shocker

Player ratings: From the determined and a hundred to a captain’s shocker

Player ratings: From the determined and a hundred to a captain’s shocker

Six best sites to buy YouTube views, subscribers and likes

Bruce McLaren engineering centre: University of Auckland plans $125m state-of-the-art facility

Meta pledges to 'defend ourselves vigorously' against Australian child harm lawsuit

Amplia uncovers new clue in pancreatic cancer drug trial

Compartir

También te puede interesar

Player ratings: From the determined and a hundred to a captain’s shocker

Player ratings: From the determined and a hundred to a captain’s shocker

Player ratings: From the determined and a hundred to a captain’s shocker

Six best sites to buy YouTube views, subscribers and likes

Bruce McLaren engineering centre: University of Auckland plans $125m state-of-the-art facility

Meta pledges to 'defend ourselves vigorously' against Australian child harm lawsuit